Építés alatt – nem éles oldal
Belépés

What researchers published on Depresszió

33 604 papers, newest first.

Showing 60 of 33 604

  • RETRACTION: Performance Assessment of Certain Machine Learning Models for Predicting the Major Depressive Disorder among IT Professionals during Pandemic Times.Computational intelligence and neuroscience
  • A novel theta-frequency tACS approach for major depressive disorder: Initial findings from an open-label pilot study.Journal of psychiatric research
  • The biological basis underlying the local brain functional changes of taVNS in treating major depressive disorder: An imaging transcriptomics study.Journal of affective disorders
  • Major depressive disorder involves motivational conflicts in emotion regulation in daily life.Journal of psychopathology and clinical science
  • Sensorimotor impairment and cognitive function across the Alzheimer's disease continuum and major depressive disorder.GeroScience
  • Baseline cortical structural features are associated with depressive and cognitive improvement in major depressive disorder.BMC psychiatry
  • ÁttekintésNeuroscience-informed psychoeducation for depression: From stress to adaptive brain recovery.Progress in brain research
  • Heterogeneous Negative Gray Matter Volume Deviations Converge on a Shared Depression Circuit Associated With Symptoms and rTMS Response.Advanced science (Weinheim, Baden-Wurttemberg, Germany)
  • [Association of resting-state functional connectivity and kynurenine metabolic pathway with cognitive impairment in patients with major depressive disorder].Zhonghua yi xue za zhi
  • Multimodal data integration for diagnosis and risk prediction of major depressive disorder in the UK Biobank.BMC psychiatry
  • Inflammatory biomarkers in late-life depression: a systematic review and meta-analysis of interleukin-1β, interleukin-6, tumor necrosis factor-α, and C-reactive protein.Brain, behavior, and immunity
  • Long Life but High Suicide Rates in Sardinia's Blue Zone: Evidence That Major Depression Alone May Not Explain the Paradox.Journal of clinical medicine
  • ÁttekintésSimultaneous EEG-fMRI in major depressive disorder: A systematic review of brain networks, neurovascular coupling, and clinical correlates.Psychiatry research
  • The m6A Reader IGF2BP2 Drives Depressive-like Behaviors Through m6A-Dependent Repression of Astrocytic GLUT1 and Glucose Metabolism.International journal of molecular sciences
  • A Hybrid Deep Learning Model (CNN-GRU) with MRMR for EEG-Based Depression Detection.Diagnostics (Basel, Switzerland)
  • ÁttekintésBeyond monoamines: a multi-systems molecular framework for major depressive disorder.Psychopharmacology
  • ÁttekintésThe Multidimensional Pathogenesis of Susceptibility to Depression in Sjögren's Syndrome: An Integrated Approach from Immune-Inflammatory to Psychosocial Factors.International journal of molecular sciences
  • Choroid plexus volume as a marker of chronotherapeutic responsiveness in major depressive disorder.Brain, behavior, and immunity
  • ÁttekintésDextromethorphan-Bupropion-Esketamine Triadic Pharmacology: Molecular Targets, Enzymatic Interactions, and Risk-Benefit Assessment of a Three-Agent Combination for Treatment-Resistant Depression.International journal of molecular sciences
  • Temporal Trends in the Burden of Major Depressive Disorder and Dysthymia in Asia, 1990-2023: Findings from the Global Burden of Disease Study 2023.Healthcare (Basel, Switzerland)
  • Investigating working memory and brain activation in major depressive disorder with and without insomnia: insights from functional near-infrared spectroscopy (fNIRS).BMC psychiatry
  • Development and psychometric validation of the Subthreshold Depression Screening Scale for Older Adults (StDSS-OA): a multiphase scale development study.BMC psychiatry
  • 2-AG as a potential biomarker for predicting response to short-term fluoxetine treatment in a mouse model of depression.Translational psychiatry
  • Szisztematikus áttekintésDepression in autism spectrum disorder: a scoping review of pharmacologic, neuromodulation, and psychosocial interventions.Frontiers in psychiatry
  • Prospective memory deficit associated with major depressive disorder: Causality, clinical impact, and potential molecular mechanisms.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
  • Flavonoids as Prospective Therapeutic Agents in Targeting Neurotrophic Signalling, HPA Axis Dysregulation, and Neuroinflammation in Depression.Mini reviews in medicinal chemistry
  • Altered individual-level morphological similarity brain networks in late-life subthreshold depression: Preserved global topology with selective nodal and sub-network disruptions.International psychogeriatrics
  • Szisztematikus áttekintésPrevalence of depression in childhood-onset systemic lupus erythematosus: a systematic review and meta-analysis.Frontiers in pediatrics
  • Genome-wide DNA methylation study uncovers epigenetic markers associated with early life stress in individuals with major depressive disorder.Psychiatry and clinical neurosciences
  • ÁttekintésInflammaging and Cellular Senescence in Postmenopausal Depression: Linking Estrogen Deficiency, Immune Dysregulation, and Brain Aging.FASEB journal : official publication of the Federation of American Societies for Experimental Biology
  • Vizsgálati eredménySmartphone-Delivered Cognitive Behavioral Digital Therapeutic for Children and Adolescents With Major Depressive Disorder: Protocol for a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.JMIR research protocols
  • Beyond Major Depressive Disorder: Why DSM-6 Should Recognize a Non-Melancholic Depressive Disorder.The American journal of psychiatry
  • Association between platelet-to-albumin ratio and major depressive disorder: findings from a Chinese clinical cohort supported by population-based evidence.Frontiers in psychiatry
  • FEV1 mediates the effect of major depressive disorder on asthma phenotypes: Mendelian randomization.Medicine
  • Domain-level symptom improvement after ketamine and TMS-based stimulation in treatment-resistant depression: a post hoc pooled analysis.Psychiatry research
  • No Significant Differences in Antidepressant Remission and Response Rates Between Anxious and Nonanxious Depression: A Multicenter Study in Taiwan.Depression and anxiety
  • Ketamine for Treatment-Resistant Depression.Journal of the American Psychiatric Nurses Association
  • Trapped in time: a collapse of temporal irreversibility and remodeling of causal connectivity in major depressive disorder.Translational psychiatry
  • Excess copper compromises hippocampal function in major depressive disorder: a study on clinical and animal evidence.Translational psychiatry
  • Nogo-related frontal theta-band activity after magnetic seizure therapy in treatment-resistant depression: an exploratory task-based EEG study.Frontiers in psychiatry
  • Integrative transcriptomics reveals an ECM/PNN-high astrocyte state and cross-tissue biomarkers in major depressive disorder.Frontiers in molecular neuroscience
  • Integrated machine learning, single-cell RNA sequencing, and experimental validation for exploratory investigation of Fructus Aurantii in treating major depressive disorder.BMC complementary medicine and therapies
  • Managing coexisting depression and substance use disorder: insights from clinical experience.Frontiers in psychiatry
  • Effectiveness of Esketamine as a Treatment for Depression: A Real-World Survey of Disease Improvement.CNS spectrums
  • Effect of Adjunctive Cariprazine Treatment on Anxiety and Somatization Symptoms in Patients with Major Depressive Disorder: A Post Hoc Analysis.CNS spectrums
  • Changes in brain structural connectivity networks are associated with electroconvulsive therapy efficacy in adolescents with major depressive disorder and suicidal ideation.Psychiatry research. Neuroimaging
  • Cariprazine for the Adjunctive Treatment of Major Depressive Disorder: Results of a Randomized Phase 3 Placebo-Controlled Study (Study 301).CNS spectrums
  • Zuranolone, a Positive Allosteric Modulator of the GABAA Receptor: Hypothesized Mechanism of Action in Major Depressive Disorder.CNS spectrums
  • Zuranolone Safety and Tolerability in Adults with Postpartum Depression: Analyses from SKYLARK, a 50 mg Placebo-Controlled Study.CNS spectrums
  • Health-Related Quality of Life and Healthcare Resource Use: Comparison of Patients with Bipolar I Disorder and Potentially Misdiagnosed Depression.CNS spectrums
  • Clinical and neural effects of a hybrid accelerated-maintenance iTBS protocol in adolescents with major depressive disorder.Translational psychiatry
  • Electroconvulsive therapy for the treatment of depression: from convulsive treatment to precision neuromodulation.Expert review of medical devices
  • Coping in Mid-to-Late Life and the Risk of Major Depressive Disorder Among Older Adults: A 15-Year Population-Based Cohort Study.International journal of geriatric psychiatry
  • Change in Depressive Symptoms Following Esketamine Initiation among Patients with Treatment-Resistant Depression in a Real-World Setting.CNS spectrums
  • Mental Health-Related Healthcare Resource Use and Costs of Medicaid Beneficiaries with Treatment Resistant Depression Receiving Interventional Therapy.CNS spectrums
  • PreprintAcute stress reorganizes pregenual cingulate and subthalamic coupling to approach-avoidance decisions in remitted depression.bioRxiv : the preprint server for biology
  • Role of External Factors in the Severity of Dissociation Experienced by Treatment- Resistant Depression Patients Following Esketamine Administration.CNS spectrums
  • Cost Efficiency of Esketamine Nasal Spray Versus Quetiapine for Treatment Resistant Depression.CNS spectrums
  • ÁttekintésTreatment-Resistant Depression Is Not a Single Disorder.Journal of psychiatric practice
  • Cariprazine as Adjunctive Treatment for Major Depressive Disorder: Benefit and Risk Assessment Using Number Needed to Treat and Number Needed to Harm.CNS spectrums